๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Adalimumab - Medicines in Ireland

42 authorised products containing Adalimumab, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 42 authorised medicines
MedicineActive substanceLicence holderStatus
AMGEVITA 20 mg solution for injection in pre-filled syringe
EU/1/16/1164/001
Adalimumab Amgen Europe B.V., โ€”
AMGEVITA 20 mg solution for injection in pre-filled syringe
EU/1/16/1164/010
Adalimumab Amgen Europe B.V., โ€”
AMGEVITA 40 mg solution for injection in pre-filled pen
EU/1/16/1164/014- 016
Adalimumab Amgen Europe B.V., โ€”
AMGEVITA 40 mg solution for injection in pre-filled syringe
EU/1/16/1164/002-009
Adalimumab Amgen Europe B.V., โ€”
AMGEVITA 40 mg solution for injection in pre-filled syringe
EU/1/16/1164/011-013
Adalimumab Amgen Europe B.V., โ€”
AMGEVITA 80 mg solution for injection in pre-filled pen
EU/1/16/1164/020- 022
Adalimumab Amgen Europe B.V., โ€”
AMGEVITA 80 mg solution for injection in pre-filled syringe
EU/1/16/1164/017-019
Adalimumab Amgen Europe B.V., โ€”
Amsparity 20 mg solution for injection in pre-filled syringe
EU/1/19/1415/001
Adalimumab Pfizer Service Company BVBA โ€”
Amsparity 40 mg solution for injection in pre-filled pen
EU/1/19/1415/007-010
Adalimumab Pfizer Service Company BVBA โ€”
Amsparity 40 mg solution for injection in pre-filled syringe
EU/1/19/1415/003-006
Adalimumab Pfizer Service Company BVBA โ€”
Amsparity 40 mg/0.8 ml solution for injection
EU/1/19/1415/002
Adalimumab Pfizer Service Company BVBA โ€”
Hefiya 20 mg solution for injection in pre-filled syringe
EU/1/18/1287/007
Adalimumab Sandoz GmbH โ€”
Hefiya 40 mg solution for injection in pre-filled pen
EU/1/18/1287/004-006
Adalimumab Sandoz GmbH โ€”
Hefiya 40 mg solution for injection in pre-filled syringe
EU/1/18/1287/001-003
Adalimumab Sandoz GmbH โ€”
Hefiya 80 mg solution for injection in pre-filled pen
EU/1/18/1287/010-011
Adalimumab Sandoz GmbH โ€”
Hefiya 80 mg solution for injection in pre-filled syringe
EU/1/18/1287/008-009
Adalimumab Sandoz GmbH โ€”
Hukyndra 20 mg solution for injection in pre-filled syringe
EU/1/21/1589/010
Adalimumab Stada Arzneimittel AG โ€”
Hukyndra 40 mg solution for injection in pre-filled pen
EU/1/21/1589/004-006
Adalimumab Stada Arzneimittel AG โ€”
Hukyndra 40 mg solution for injection in pre-filled syringe
EU/1/21/1589/001-003
Adalimumab Stada Arzneimittel AG โ€”
Hukyndra 80 mg solution for injection in pre-filled pen
EU/1/21/1589/008-009
Adalimumab Stada Arzneimittel AG โ€”
Hukyndra 80 mg solution for injection in pre-filled syringe
EU/1/21/1589/007
Adalimumab Stada Arzneimittel AG โ€”
Hulio
EU/1/18/1319/001-007
Adalimumab Biosimilar Collaborations Ireland Limited โ€”
Hulio 20 mg solution for injection in pre-filled syringe
EU/1/18/1319/009-010
Adalimumab Biosimilar Collaborations Ireland Limited โ€”
Humira 20 mg solution for injection in pre-filled syringe
EU/1/03/256/022
Adalimumab AbbVie Deutschland GmbH & Co. KG โ€”
Humira 40 mg/0.8 ml solution for injection
EU/1/03/256/1-10
Adalimumab AbbVie Deutschland GmbH & Co. KG โ€”
Humira 80 mg solution for injection in pre-filled syringe
EU/1/03/256/020
Adalimumab AbbVie Deutschland GmbH & Co. KG โ€”
Hyrimoz 20 mg solution for injection in pre-filled syringe
EU/1/18/1286/007
Adalimumab Sandoz GmbH โ€”
Hyrimoz 40 mg solution for injection in pre-filled pen
EU/1/18/1286/004-006
Adalimumab Sandoz GmbH โ€”
Hyrimoz 40 mg solution for injection in pre-filled syringe
EU/1/18/1286/001-003
Adalimumab Sandoz GmbH โ€”
Hyrimoz 80 mg solution for injection in pre-filled pen
EU/1/18/1286/010-011
Adalimumab Sandoz GmbH โ€”
Hyrimoz 80 mg solution for injection in pre-filled syringe
EU/1/18/1286/008-009
Adalimumab Sandoz GmbH โ€”
IDACIO 40 mg Solution for injection
EU/1/19/1356/002
Adalimumab Fresenius Kabi Deutschland GmbH โ€”
IDACIO 40 mg Solution for injection
EU/1/19/1356/003
Adalimumab Fresenius Kabi Deutschland GmbH โ€”
IDACIO 40 mg/0.8 ml Solution for injection
EU/1/19/1356/001
Adalimumab Fresenius Kabi Deutschland GmbH โ€”
Imraldi 40 mg solution for injection in pre-filled pen
EU/1/17/1216/005-008
Adalimumab Samsung Bioepis NL B.V. โ€”
Imraldi 40 mg solution for injection in pre-filled syringe
EU/1/17/1216/001-004
Adalimumab Samsung Bioepis NL B.V. โ€”
Imraldi 40 mg/0.8 ml solution for injection
EU/1/17/1216/009
Adalimumab Samsung Bioepis NL B.V. โ€”
Libmyris
EU/1/21/1590/001-006
Adalimumab Stada Arzneimittel AG โ€”
Libmyris 80 mg solution for injection in pre-filled syringe
EU/1/21/1590/007
Adalimumab Stada Arzneimittel AG โ€”
Yuflyma
EU/1/20/1513/001-012
Adalimumab Celltrion Healthcare Hungary Kft. โ€”
Yuflyma
EU/1/20/1513/013-016
Adalimumab Celltrion Healthcare Hungary Kft. โ€”
Yuflyma 20 mg solution for injection in pre-filled syringe
EU/1/20/1513/017
Adalimumab Celltrion Healthcare Hungary Kft. โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.